Ambev S.A. (NYSE: ABEV) – For an in-depth report on Ambev S.A. follow: www.BullTrends.com/stockquote/ABEV
Shares of ABEV closed down about 5% on Wednesday with nearly 40 million shares traded. Average trading volume for the stock is just around 9.7 million shares. The Brazilian company’s drop came after it was revealed that Brazil plans to institute higher taxes on beer prior to the World Cup this summer. Bloomberg reported that the Brazilian government will announce today a plan to increase taxes on beverages including beer, soda and bottled water beginning on June 1.
Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) - For an in-depth report on Avanir Pharmaceuticals, Inc. follow: www.BullTrends.com/stockquote/AVNR
Shares of Avanir Pharmaceuticals closed up 45.61% on about 14.4 million shares traded on Wednesday. It was one of the most active stocks traded on the NASDAQ. The U.S. District Court for the District of Delaware ruled in Avanir’s favor in its patent infringement lawsuit against Par Pharmaceuticals and Impax Laboratories over NUEDEXTA.
Rite Aid Corporation (NYSE: RAD) – For an in-depth report on Rite Aid Corporation follow: www.BullTrends.com/stockquote/RAD
Shares of Rite Aid Corporation closed up 2.96% on about 41 million shares traded. The stock was one of the most active stocks on the NYSE on Wednesday coming just 7 cents shy of its yearly high during intra-day trading. Company Chief Financial Officer Frank Vitrano sold 1,913,925 Rite Aid shares for $13,544,847, an average of $7.08 each.
InsPro Technologies Corporation (OTC: ITCC) - For an in-depth report on InsPro Technologies Corporation follow: www.BullTrends.com/stockquote/ITCC
Shares of ITCC closed up over 200% on Wednesday with about 7.5 million shares traded. The stock was one of the biggest gainers in the OTC market despite no news released. InsPro Technologies Corporation, through its subsidiary, InsPro Technologies, LLC, provides Web-based insurance administration software applications for insurance carriers and third party administrators.
Disclosure: BullTrends.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.